Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.

Myra Vision, a Shifamed portfolio company, today announced the first patient enrolled in its ADAPT clinical study evaluating ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

The results of a new study show donor corneas not suitable for transplants may serve as a more effective alternative to traditional tissue for patients needing tissue to cover a glaucoma shunt, ...

The multi‐site VITA trial, a prospective pilot study designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate® device, enrolled and treated 15 subjects (mean ...

Discussions from the EnVision Summit 2025 highlighted several clinical and surgical challenges that are expected to shape ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NASHVILLE, Tenn. — Patients with glaucoma who underwent ...

Company’s first-of-its-kind titratable glaucoma therapy system aims to optimize intraocular pressure (IOP) reduction for patients with moderate to severe glaucoma Results demonstrate significant IOP ...

The use of aqueous shunts for the management of refractory glaucoma is increasing compared with trabeculectomy. The number of shunts being placed increased 184% from 1995 to 2004. Commonly used ...

The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.

Glaucoma can be treated with eye drops, pills, laser surgery, traditional incisional surgery, newer minimally invasive surgical alternatives or a combination of these methods. The goal of any ...

For example, currently, CMS considers ICD-9-CM series 365.10-365.15, open-angle glaucoma as medically necessary to perform Category III code 0192T. Operative documentation must support all conditions ...